drugset / Trial / NCT03338205

The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus

NCT03338205

Phase 3 Withdrawn Augusta University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this investigation is to perform a pilot study assessing the safety and utility of intravenous ketamine as an adjuvant therapy in the emergency department setting for pediatric patients in acute status asthmaticus who have failed standard emergency therapy.

Timeline

Start
2020-01
Primary completion
2021-12
Completion
2022-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 1 mg/kg Intravenous

Indications